Consistently, ALKBH3 exhibited a significant negative correlation with SP100 in a group of 87 metastatic melanoma samples (deposited in GEO database: GSE7553, R = –0.227, P= 0.035, Supplementary Figure S6). Here, ALKBH3 is linked to metastatic melanoma.